Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06615986 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis

StatusCompleted
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed Show 4 more changesShow less
    • Final enrollment: 46 participants (planned 100)
    • Primary completion date changed from estimate of Apr 15, 2027 to Jul 28, 2026
    • Eligibility criteria expanded, about 15 words
    • Site details revised
  2. Minor 8 versions Re-verified since Mar 14, 2025, no change to tracked fieldsv29-v36
  3. Minor Study description shortened, about 2 wordsv28
  4. Minor 3 versions Re-verified since Dec 14, 2024, no change to tracked fieldsv25-v27
  5. Minor Start date: Oct 29, 2024 to Nov 15, 2024v24
Show 22 earlier versionsHide 22 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 4, 2024 to Oct 29, 2024
    • Site details revised
    v23
  2. Minor Start date: Nov 3, 2024 to Nov 4, 2024v22
  3. Minor Start date: Oct 31, 2024 to Nov 3, 2024v21
  4. Minor Start date: Oct 30, 2024 to Oct 31, 2024v20
  5. Minor Start date: Oct 29, 2024 to Oct 30, 2024v19
  6. Minor Start date: Oct 28, 2024 to Oct 29, 2024v18
  7. Minor Start date: Oct 25, 2024 to Oct 28, 2024v17
  8. Minor Start date: Oct 24, 2024 to Oct 25, 2024v16
  9. Minor Start date: Oct 23, 2024 to Oct 24, 2024v15
  10. Minor Start date: Oct 21, 2024 to Oct 23, 2024v14
  11. Minor Start date: Oct 20, 2024 to Oct 21, 2024v13
  12. Minor Start date: Oct 17, 2024 to Oct 20, 2024v12
  13. Minor Start date: Oct 16, 2024 to Oct 17, 2024v11
  14. Minor Start date: Oct 15, 2024 to Oct 16, 2024v10
  15. Minor Start date: Oct 14, 2024 to Oct 15, 2024v9
  16. Minor Start date: Oct 13, 2024 to Oct 14, 2024v8
  17. Minor Start date: Oct 9, 2024 to Oct 13, 2024v7
  18. Minor Start date: Oct 8, 2024 to Oct 9, 2024v6
  19. Minor Start date: Oct 7, 2024 to Oct 8, 2024v5
  20. Minor Start date: Oct 4, 2024 to Oct 7, 2024v4
  21. Minor Start date: Oct 3, 2024 to Oct 4, 2024
    • Study description expanded, about 48 words
    • Eligibility criteria shortened, about 1 word
    v3
  22. Minor Start date: Oct 2, 2024 to Oct 3, 2024v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Human intestines are home to a complex gut flora, also called microbiome; this is a natural occurring community of bacteria, fungi, yeast, and viruses. Changes in the balances of the gut flora can lead to illnesses, such as diabetes, colorectal cancer, and inflammatory bowel diseases. Synbiotics are dietary supplements people take to maintain proper balances of their gut flora aiming to improve health. Objective: To find out if a synbiotic supplement can increase the type and amount of beneficial gut bacteria in healthy people as well as improve cardio-vascular protection markers. The supplement contains a natural sugar from human milk. Eligibility: Healthy people aged 18 years or older who eat a typical western diet. They must take no medications (with a few exceptions). Design: Participants will have 2 clinic visits. The first visit will start with screening. They will have a blood test and wait around 2 hours for the results of the blood test. The test will determine if they are eligible for the study. Eligible participants will have additional blood drawn during the screening visit. They will be given a kit to collect a stool sample at home with instructions. They may complete a 3-day food diary. They will meet with a nutritionist and a physician by phone, telehealth, or in person. The supplement is a powder that is mixed with water or another noncarbonated drink. Participants will drink 2 doses per day. Each dose will be 1 hour before or after a meal. The second visit will be about 8 weeks after the first. Participants may repeat the 3-day food diary and nutrition visit. The physical exam, blood tests, and stool sample will be repeated.
Trial Details
NCT Number NCT06615986
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)
Healthy Volunteers
Enrollment 46 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov